Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHIP Trial: Chemo-Immunotherapy in Platinum Resistant Ovarian Cancer
NCT01639885Phase 2Completed
- Sponsor
- Leiden University Medical Center
- Start
- Aug 2011
- Primary completion
- Jan 2014
- Modality
- Peptides, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of p53 synthetic long peptide vaccine in ovarian cancer, sponsored by Leiden University Medical Center. Started Aug 2011; status: completed.
02
Drugs
p53 synthetic long peptide vaccine
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT01639885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01639885.